U.S. equities stumbled as AI-bubble concerns overwhelmed otherwise resilient fundamentals. Click here to read more on REITs here.
Why DHC Stock dropped -2.45% Today — RQD Quant Desk Flash
Diversified Healthcare Trust of (DHC) carries a Roarable Rating of E (Strong Sell) with 25/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DHC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Diversified Healthcare Trust of (NASDAQ: DHC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $7.55 (-2.45% 1D, market cap $1.87B). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 3/20. Across 1097 tracked Financials issuers, DHC ranks #1059 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DHC compare to BXMT and ARR in the Financials sector?
▼
Within the Financials sector (Real Estate Investment Trusts), DHC carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -17.2%. By comparison, BXMT (Blackstone Mortgage Trust Inc.) holds a D grade (50/100 RQD, P/E 16.7x, ROIC 3.1%, cap $1.88B) and ARR (ARMOUR Residential REIT Inc.) posts a D grade (49/100 RQD, P/E 5.9x, ROIC 14.3%, cap $1.84B). Among the 5-stock peer group, ARR leads on earnings multiple (5.9x) while ARR leads on capital efficiency (14.3% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DHC?
▼
Per DHC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001075415), Diversified Healthcare Trust of generated $1.54B in revenue (+2.8% YoY), -$285.9M in net income, and -$19.6M in free cash flow against $4.36B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where to Enter $DHC, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±6.3% realized swing band)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a DHC Turnaround Squeeze
While DHC currently carries a cautious 25/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Financials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($7.76) and Max Pain ($7.93) forces dealer call-delta covering toward $10.14.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why DHC Stock dropped -2.45% Today — RQD Quant Desk Flash
Diversified Healthcare Trust of (DHC) dropped -2.45% to $7.55, trading at 63% of its 52-week range ($3.92 – $9.66). Stretched risk/reward at current multiples (-17% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 63% of its 52-week range ($3.92 – $9.66) with RSI-14 at 48.7 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±6.3% around $7.55 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
NEWTON, Mass., November 02, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended September 30, 2026, and provided updated full year 2026 financial guidance, which c
Why this new lease matters for Diversified Healthcare Trust stock Diversified Healthcare Trust (DHC) has reshaped part of its portfolio by signing a 15 year triple net lease with subsidiaries of The Ensign Group for seve
NEWTON, Mass., October 08, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will
NEWTON, Mass., October 06, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its third quarter 2026 financial results after the Nasdaq closes on Monday, Novemb
Strong operational momentum and improved leverage position the company for continued growth despite near-term transition headwinds.
Yahoo Finance coverage on DHC stock catalysts, institutional flow, and earnings outlook.
Yahoo Finance coverage on DHC stock catalysts, institutional flow, and earnings outlook.
NEWTON, Mass., July 06, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its second quarter 2026 financial results after the Nasdaq closes on Monday, August 3
Does Diversified Healthcare (DHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DHC)
- ✓Walkthrough of DHC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
DHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +2.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DHC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for DHC. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DHC)
1. Head-to-Head Financials Peer Comparison (DHC vs. BXMT, ARR, RLJ, SMA)
Industry: Real Estate Investment Trusts (172 Tracked Issuers)Across 1097 tracked Financials securities in the Roarable RQD universe, Diversified Healthcare Trust of (DHC) ranks #1059 by composite RQD confidence (25/100, grade E) and #435 by equity capitalization ($1.87B). Within this direct 5-issuer industry benchmark cohort, ARR leads on earnings valuation at 5.9x trailing P/E, while ARR leads on capital efficiency and profitability with 14.3% ROIC and — gross margin. SMA currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with DHC at 25/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DHC
ACTIVE
Diversified Healthcare Trust of | E | 25/100 | — | — | -17.2% | -2.45% | $1.87B | Benchmark Subject |
| BXMT Blackstone Mortgage Trust Inc. | D | 50/100 | 16.7x | — | 3.1% | -1.95% | $1.88B | /bxmt-vs-dhc → |
| ARR ARMOUR Residential REIT Inc. | D | 49/100 | 5.9x | — | 14.3% | -2.26% | $1.84B | /arr-vs-dhc → |
| RLJ RLJ Lodging Trust of $0.01 par value | C- | 60/100 | 67.9x | — | 1.3% | -1.33% | $1.94B | /rlj-vs-dhc → |
| SMA SmartStop Self Storage REIT Inc. | C | 63/100 | — | — | 4.1% | -1.61% | $2.06B | /sma-vs-dhc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001075415 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Diversified Healthcare Trust of (DHC) reported GAAP revenue of $1.54B (+2.8% vs. FY2024 revenue of $1.50B , and +9.0% cumulative change since FY2023) , GAAP net income of -$285.9M, operating cash flow of -$19.6M, and free cash flow of -$19.6M (-117.5% YoY). On the balance sheet, DHC closed FY2025 with $4.36B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.54B | -$285.9M | -$19.6M | -$19.6M | $4.36B | — |
| FY2024 (FY) | 2024-12-31 | $1.50B | -$370.3M | $112.2M | $112.2M | $5.14B | — |
| FY2023 (FY) | 2023-12-31 | $1.41B | -$293.6M | $10.5M | $10.5M | — | — |
3. DHC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DHC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Diversified Healthcare Trust of (NASDAQ: DHC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $7.55 (-2.45% 1D, market cap $1.87B). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 3/20. Across 1097 tracked Financials issuers, DHC ranks #1059 in composite RQD confidence.
How does DHC compare to BXMT and ARR in the Financials sector?
Within the Financials sector (Real Estate Investment Trusts), DHC carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -17.2%. By comparison, BXMT (Blackstone Mortgage Trust Inc.) holds a D grade (50/100 RQD, P/E 16.7x, ROIC 3.1%, cap $1.88B) and ARR (ARMOUR Residential REIT Inc.) posts a D grade (49/100 RQD, P/E 5.9x, ROIC 14.3%, cap $1.84B). Among the 5-stock peer group, ARR leads on earnings multiple (5.9x) while ARR leads on capital efficiency (14.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DHC?
Per DHC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001075415), Diversified Healthcare Trust of generated $1.54B in revenue (+2.8% YoY), -$285.9M in net income, and -$19.6M in free cash flow against $4.36B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DHC trading relative to its 50-day, 200-day, and 52-week technical levels?
DHC last traded at $7.55 (-2.45% on volume of 3,571,351 shares), positioning the stock -2.71% below its 50-day simple moving average ($7.76) and -3.21% below its 200-day simple moving average ($7.80). Across its 52-week range of $3.92 to $9.66, DHC sits at the 63.2% percentile with a 14-day RSI of 48.7 (NEUTRAL RANGE) and an implied next-earnings move of ±6.3% ($7.07 to $8.03).
DHC — Diversified Healthcare Trust of: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Diversified Healthcare Trust of (DHC) earns a live Roarable RQD composite score of 25/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $7.55 (-2.45% 1D, market capitalization $1.87B).
- Fundamental Cash Engine (3/20): Anchored by return on invested capital (ROIC) of -17.2%, gross margin of —, operating margin of —, and free cash flow yield of -1.02%.
- Whale 13F & Options Flow (9/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (3/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 2/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
.9B. Reported revenue was $1.54B for FY 2025.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Diversified Healthcare Trust of (DHC) reported $1.54B in annual revenue (up from $1.50B in FY2024, +2.8% YoY) and -$285.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.41B revenue, -$293.6M net income) through FY2025, DHC scaled operating cash flow to -$19.6M and free cash flow to -$19.6M, backed by $4.36B in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (E • RQD 25/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of -1.02% and institutional whale pillar of 9/20. With Fundamental Cash Engine at 3/20 and Institutional Whale Flow at 9/20, sustained execution supports upside toward the upper end of the $3.92 – $9.66 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Operating in Real Estate Investment Trusts (Financials), DHC carries a macro regime beta of 1.00 and gross margin of —.
- Key Question #1: Can DHC sustain or expand its — operating margin and -17.2% ROIC against Real Estate Investment Trusts peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $1.54B and free cash flow of -$19.6M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is DHC's equity valuation to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
DHC Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Diversified Healthcare Trust of (DHC) • Click "Debate This Headline" to argue it in the Roar Pit below
U.S. equities stumbled as AI-bubble concerns overwhelmed otherwise resilient fundamentals. Click here to read more on REITs here.
NEWTON, Mass., November 02, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended September 30, 2026, and provided updated full year 2026 financial guidance, which c
Why this new lease matters for Diversified Healthcare Trust stock Diversified Healthcare Trust (DHC) has reshaped part of its portfolio by signing a 15 year triple net lease with subsidiaries of The Ensign Group for seve
NEWTON, Mass., October 08, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will
NEWTON, Mass., October 06, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its third quarter 2026 financial results after the Nasdaq closes on Monday, Novemb
Strong operational momentum and improved leverage position the company for continued growth despite near-term transition headwinds.
Yahoo Finance coverage on DHC stock catalysts, institutional flow, and earnings outlook.
Yahoo Finance coverage on DHC stock catalysts, institutional flow, and earnings outlook.
DHC Bull vs. Bear Conversation Board — What's Your Call at $7.55?
Whale 13F flow scores 12 of 20, indicating institutional accumulation and options positioning that is stronger than the other pillars.
Here is why I am bullish on DHC here at $7.78: Whale 13F flow scores 12 of 20, indicating institutional accumulation and options positioning that is stronger than the other pillars.. Compare DHC's 0.0% operating margin and -17.2% ROIC against the rest of Real Estate Investment Trusts. As long as cash conversion holds up, dips toward $7.39 are getting bought.
@RiskArb_Desk Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Real Estate Investment Trusts. If gross margin (0.0%) holds, EPS grows into the multiple faster than bears think.
ROIC of -17.2% and FCF yield of -1.02% anchor the fundamental cash engine at 2 of 20, alongside net losses in each reported period.
I respect the product at Diversified Healthcare Trust of, but the stock at $7.78 is a different story. ROIC of -17.2% and FCF yield of -1.02% anchor the fundamental cash engine at 2 of 20, alongside net losses in each reported period.. FCF yield is -1.02% and RQD sits at 25/100 (E) — why pay up here when you can wait for next quarter's numbers?